Article
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
Cancer science - 1 Mar 2010
Han Sae-Won, Oh Do-Youn, Im Seock-Ah, Park Sook Ryun, Lee Keun-Wook, Song Hong Suk, Lee Nam-Su, Lee Kyung Hee, Choi In Sil, Lee Moon Hee, Kim Min A, Kim Woo Ho, Bang Yung-Jue, Kim Tae-You
Abstract excerpt
Cetuximab is a monoclonal antibody targeting epidermal growth factor receptor (EGFR). The present study investigated the association between germline genetic polymorphisms and the treatment outcome of cetuximab plus modified leucovovin, fluorouracil, and oxaliplatin (FOLFOX)6 chemotherapy in adva...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.